In complicated UTIs, cefepime-taniborbactam increased treatment success vs. meropenem at 19 to 23 d.
Ann Intern Med
; 177(6): JC67, 2024 Jun.
Article
in En
| MEDLINE
| ID: mdl-38830218
ABSTRACT
SOURCE CITATION Wagenlehner FM, Gasink LB, McGovern PC, et al; CERTAIN-1 Study Team. Cefepime-taniborbactam in complicated urinary tract infection. N Engl J Med. 2024;390611-622. 38354140.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Tract Infections
/
Cefepime
/
Meropenem
/
Anti-Bacterial Agents
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Ann Intern Med
Year:
2024
Document type:
Article